Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	72.9	76.68	108.91	77.83	63.56
Cash & Short-Term Investments	72.9	76.68	108.91	77.83	63.56
Cash Growth	-4.92%	-29.60%	39.93%	22.45%	586.84%
Prepaid Expenses	1.6	1.59	1.64	1.48	1.32
Restricted Cash	-	-	0.4	0.39	0.05
Other Current Assets	-	-	-	0.05	-
Total Current Assets	74.51	78.26	110.94	79.75	64.93
Property, Plant & Equipment	2.07	2.87	2.95	0.64	1.03
Other Long-Term Assets	0.32	0.31	0.3	-	0.44
Total Assets	76.9	81.45	114.19	80.39	66.4
Accounts Payable	7.57	7.95	10.13	5.54	4.34
Current Portion of Leases	0.58	0.54	0.5	0.31	0.43
Current Unearned Revenue	-	-	-	1	-
Total Current Liabilities	8.15	8.49	10.63	6.84	4.77
Long-Term Leases	0.99	1.57	2.08	0	0.31
Long-Term Unearned Revenue	35	35	35	-	-
Total Liabilities	44.14	45.07	47.71	6.84	5.08
Common Stock	0.03	0.03	0.03	0.02	0.02
Additional Paid-In Capital	408.55	373.93	355.22	329.27	292.28
Retained Earnings	-375.83	-337.58	-288.77	-255.75	-230.97
Shareholders' Equity	32.76	36.38	66.48	73.55	61.32
Total Liabilities & Equity	76.9	81.45	114.19	80.39	66.4
Total Debt	1.57	2.11	2.58	0.31	0.74
Net Cash (Debt)	71.33	74.56	106.33	77.52	62.82
Net Cash Growth	-4.34%	-29.87%	37.16%	23.39%	702.73%
Net Cash Per Share	2.37	2.80	4.40	3.77	5.18
Filing Date Shares Outstanding	31.2	29.4	25.73	22.14	19.25
Total Common Shares Outstanding	31.2	27.63	25.67	22.14	17.53
Working Capital	66.36	69.77	100.31	72.91	60.16
Book Value Per Share	1.05	1.32	2.59	3.32	3.50
Tangible Book Value	32.76	36.38	66.48	73.55	61.32
Tangible Book Value Per Share	1.05	1.32	2.59	3.32	3.50
Machinery	1.26	1.24	1.09	0.68	0.6

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q